Destiny’s SA trial shows fast acting antibiotic too quick for disease resistance
Destiny Pharma, a UK clinical stage drug company, found its antibacterial drug, exeporfinium chloride (XF-73), demonstrated a rapid, anti-staphylococcal effect (killed the bacteria) after just 1 day, showing a statistical difference against placebo, in their US clinical trial.
Click on this link for more information.
for more information.
